News

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
Detailed price information for Xoma Royalty Corporation (XOMA-Q) from The Globe and Mail including charting and trades.